RESUMEN
Transcatheter aortic valve (TAVI) is the treatment of choice in patients with severe symptomatic aortic stenosis at high surgical risk. Recent data have also shown favorable results in patients considered to have an intermediate operative risk, which broadens the application of this new technology. Despite its success, the TAVI procedure has been associated with life-threatening complications. Advances in preoperative screening and patient selection have reduced the incidence of these complications. When these complications occur, early recognition and rapid management are essential. The purpose of this review is to describe non-rhythmic mechanical complications attributable to TAVI procedures with their predictive factors, how to prevent and manage them.
Asunto(s)
Estenosis de la Válvula Aórtica/cirugía , Complicaciones Posoperatorias/terapia , Reemplazo de la Válvula Aórtica Transcatéter/efectos adversos , Enfermedades Vasculares/prevención & control , Rotura de la Aorta/etiología , Rotura de la Aorta/prevención & control , Insuficiencia de la Válvula Aórtica/etiología , Insuficiencia de la Válvula Aórtica/prevención & control , Isquemia Encefálica/etiología , Isquemia Encefálica/prevención & control , Taponamiento Cardíaco/etiología , Taponamiento Cardíaco/prevención & control , Oclusión Coronaria/etiología , Oclusión Coronaria/prevención & control , Humanos , Selección de Paciente , Complicaciones Posoperatorias/etiología , Calcificación Vascular/complicaciones , Enfermedades Vasculares/etiologíaAsunto(s)
Técnicas de Imagen Sincronizada Cardíacas , Miocarditis/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Enfermedad Aguda , Adulto , Biomarcadores/sangre , Medios de Contraste , Diagnóstico Diferencial , Ecocardiografía , Electrocardiografía , Humanos , Yopamidol/análogos & derivados , Imagen por Resonancia Magnética , Masculino , Interpretación de Imagen Radiográfica Asistida por ComputadorRESUMEN
OBJECTIVE: Determination of clinical and angiographic characteristics of myocardial infarctions related to sport. METHODS: Retrospective study of acute coronary syndromes with ST elevation related to sport treated with interventional cardiology from 2006 to 2013. RESULTS: Sixteen patients were included. They are mostly men (15/16), aged 24-65 years (over 35 years old in 13 cases) with few cardiovascular risk factors, most frequently heredity or smoking. Myocardial infarctions usually occur during the practice of sports (13/16), with serious rhythmic complications in three of the cases. On angiography, most patients have single vessel disease (12/16). CONCLUSION: Myocardial infarction related to sports affects a male population aged over 35 years old with few cardiovascular risk factors, most often single vessel disease, making the preventative screening uneasy. Other studies investigating larger populations, assessing previous clinical events (symptoms, results of stress tests), evaluating the impact of competition and integrating sudden deaths would improve the screening and the treatment of sport-related myocardial infarctions.
Asunto(s)
Angiografía Coronaria , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/etiología , Deportes , Adulto , Anciano , Diagnóstico Diferencial , Prueba de Esfuerzo , Femenino , Sistema de Conducción Cardíaco/fisiopatología , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/fisiopatología , Estudios Retrospectivos , Factores de Riesgo , Fumar/efectos adversosRESUMEN
The present study sought to validate the use of glycery1-2-oley-1,3-bis-[7-(3-amino-2,4,6-triiodophenyl)- heptanoate] (DHOG) contrast agent for mouse spleen tumor and liver metastasis imaging by high-resolution X-ray microtomography. Three groups of female nude mice were compared: controls (n = 5), and mice injected with 2.5 x 10(6) STC1 tumor cells in the spleen, imaged at 15 days (group G15, n = 5) and at 30 days (group G30, n = 5, of which one died before imaging). Micro-CT scans (X-ray voltage, 50 kVp; anode current, 200 microA; exposure time, 632 ms; 180 rotational steps resulting in 35 microm isotropic spatial resolution) were acquired at 0, 0.75, 2 and 4 h after i.v. injection of DHOG. CT number (Hounsfield units: HU) and contrast-to-noise ratios (CNR) were determined in three organs. Statistical analysis was performed by Mann-Whitney U-test. Contrast enhancement in normal spleen and liver increased, respectively to 1020 +/- 159 and 351 +/- 27 HU over baseline at 4 h, and 482 +/- 3 and 203 +/- 14 HU on day 6 after a single contrast injection. Automated three-dimensional reconstruction and modeling of the spleen provided accurate and quantifiable images. Spleen tumor and liver metastases did not take up DHOG, making them detectable in contrast to the increased signal in normal tissue. The smallest liver metastasis detected measured 0.3 mm in diameter. High-resolution X-ray micro-CT in living mice using DHOG contrast agent allowed visualization and volume quantification of normal spleen and of spleen tumor and its liver metastases.
Asunto(s)
Medios de Contraste/farmacología , Neoplasias Hepáticas/patología , Neoplasias del Bazo/patología , Tomografía Computarizada por Rayos X/métodos , Animales , Diagnóstico por Imagen/métodos , Femenino , Procesamiento de Imagen Asistido por Computador , Ratones , Modelos Estadísticos , Metástasis de la Neoplasia , Trasplante de NeoplasiasRESUMEN
In 94 patients with chronic hepatitis C, the pattern of integrin expression was correlated with firstly, the histological activity index, necro-inflammatory grade, and stage of fibrosis; secondly, the expression of inflammatory markers including ICAM-1; and thirdly, the extent and intensity of laminin deposition in the perisinusoidal matrix. Immunohistochemical results were evaluated according to a semi-quantitative scoring system or by image analysis. Increased beta1 expression was observed in 88.2% of cases. The expression of alpha1 and alpha5 was increased in 55% and 58.5% of cases, respectively. alpha6 chain was detected in 78.7% of cases. There were no statistically significant differences in integrin expression level according to Knodell's score, inflammatory grade, or stage of fibrosis. ICAM-1 expression was higher in patients with high scores for beta1 expression, but the differences were not statistically significant. There were significantly more patients with high scores for beta1 expression among those with continuous perisinusoidal deposition of laminin. Moreover, a close statistical correlation was observed between alpha6 induction and perisinusoidal laminin deposition (p<0.001). The results suggest that integrin up-regulation in chronic hepatitis C is more closely related to the fibrotic process than to the inflammatory lesions. This reinforces the idea that integrin induction in chronic liver disease is part of a coordinated process involved in the progression of liver fibrosis.
Asunto(s)
Hepatitis C Crónica/metabolismo , Integrinas/metabolismo , Regulación hacia Arriba , Adulto , Anciano , Distribución de Chi-Cuadrado , Femenino , Antígenos HLA-DR/metabolismo , Hepatitis C Crónica/patología , Hepatocitos/metabolismo , Humanos , Procesamiento de Imagen Asistido por Computador , Molécula 1 de Adhesión Intercelular/metabolismo , Laminina/metabolismo , Masculino , Persona de Mediana Edad , Estadísticas no ParamétricasRESUMEN
BACKGROUNDS/AIMS: Hepatocellular carcinoma usually contains continuous capillary vessels lacking the differentiation markers specific for normal sinusoidal endothelial cells. We therefore aimed to search for alterations in endothelial cell marker expression in precancerous liver lesions. METHODS: Expression of the endothelial cell markers CD31, CD34 and BNH9 was analyzed in 138 dysplastic lesions from 40 cirrhotic patients (20 with and 20 without hepatocellular carcinoma). RESULTS: No expression of the three endothelial cell markers was detected in cirrhotic nodules and in non dysplastic regenerative macronodules. The three markers were detected in 29.8% of dysplastic lesions and 47% of hepatocellular carcinomas. At least one marker was detected in 75% of dysplastic lesions and 100% of hepatocellular carcinomas. The three markers were more frequently expressed in areas of small cell than of large cell change (34 vs 10%). No correlation was found with the grade of dysplasia, the occurrence of arterialization and the association with hepatocellular carcinoma. CONCLUSIONS: Alterations in the hepatic microcirculation comparable to those observed in hepatocellular carcinoma are present in a significant proportion of dysplastic lesions of the liver and may be indirect markers of the process of liver carcinogenesis.
Asunto(s)
Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Endotelio Vascular/metabolismo , Endotelio Vascular/patología , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Lesiones Precancerosas/metabolismo , Lesiones Precancerosas/patología , Adulto , Antígenos CD34/metabolismo , Biomarcadores , Capilares/metabolismo , Capilares/patología , Carcinoma Hepatocelular/irrigación sanguínea , Carcinoma Hepatocelular/complicaciones , Diagnóstico Diferencial , Femenino , Humanos , Inmunohistoquímica , Hígado/irrigación sanguínea , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática/complicaciones , Cirrosis Hepática/metabolismo , Cirrosis Hepática/patología , Neoplasias Hepáticas/irrigación sanguínea , Neoplasias Hepáticas/complicaciones , Masculino , Persona de Mediana Edad , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/metabolismo , Lesiones Precancerosas/irrigación sanguínea , Lesiones Precancerosas/complicaciones , Estudios RetrospectivosRESUMEN
Patients with metastatic neuroblastoma are rarely curable with currently available therapy, and the search for new treatment options, which include the use of inhibitors of tumor angiogenesis, is warranted. Here, we have evaluated the efficacy of one of the most promising natural inhibitors of angiogenesis described to date, endostatin, in a human neuroblastoma xenograft model in nude mice. Murine endostatin cDNA was cloned in a bacterial expression vector, expressed as a polyHis-Endostatin fusion protein and purified on Ni2+-NTA beads. The in vitro activity of soluble endostatin was confirmed on bovine capillary endothelial cells and human umbilical vein endothelial cells. The human neuroblastoma cell line SKNAS was injected subcutaneously in the flank of nude mice and administration of the recombinant angiogenesis inhibitor started when tumors reached the size of 100 microm3. Twenty mg/kg of recombinant precipitated endostatin or PBS was subcutaneously injected daily for 12 days. Serum endostatin levels were measured using a competitive enzyme immunoassay. Tumor growth was only slowed down in endostatin-treated mice when compared to control mice, and no statistically significant difference in serum levels of endostatin was observed between endostatin-treated and control groups. The lack of correlation between serum concentration and tumor response raises concern regarding the mechanism of action of endostatin.
Asunto(s)
Inhibidores de la Angiogénesis/uso terapéutico , Colágeno/uso terapéutico , Neuroblastoma/tratamiento farmacológico , Fragmentos de Péptidos/uso terapéutico , Inhibidores de la Angiogénesis/genética , Inhibidores de la Angiogénesis/aislamiento & purificación , Inhibidores de la Angiogénesis/farmacocinética , Animales , Bovinos , Colágeno/genética , Colágeno/aislamiento & purificación , Colágeno/farmacocinética , Endostatinas , Escherichia coli/genética , Expresión Génica , Genes Bacterianos/fisiología , Vectores Genéticos , Humanos , Ratones , Trasplante de Neoplasias , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/aislamiento & purificación , Fragmentos de Péptidos/farmacocinética , Proteínas Recombinantes/uso terapéutico , Trasplante Heterólogo , Insuficiencia del TratamientoRESUMEN
The alphav integrins present on the membrane of numerous cells, mediate attachment to matrix proteins, cell proliferation, migration and survival. We studied the expression of alphav integrinis and CD47 (a beta3 chain integrin associated protein) in various forms of glomerulonephritis (GN) characterized by mesangial proliferation and/or increased mesangial matrix. In normal glomeruli, epithelial cells expressed alphavbeta3, alphavbeta5 and CD47; endothelial cells expressed alpha5beta1 and CD47; mesangial cells expressed alphavbeta5, CD47, and to a less extent alphavbeta3. In acute post infectious GN (APIGN), membrano-proliferative GN (MPGN) and diabetic nephropathy(DN), we observed that the beta3 chain, normally expressed by mesangial cells, was not detectable in the mesangium while its expression by epithelial cells was not modified. Parallel to the disappearance of alphavbeta3, the CD47 expression was decreased on the mesangial cells in MPGN, APIGN and DN. The expression of alphavbeta5 was clearly increased on podocytes and on proliferating mesangial cells in APIGN. By contrast, the mesangial expression of alphavbeta was normal or decreased in DN. The alpha5 chain of integrin, absent on normal mesangial cell, was expressed on proliferating mesangial cells in MPGN and APIGN. Thus, we observed modifications of alphavbeta3 and alphavbeta5 expression during human GN. The modulations of alphavbeta3 and alphavbeta5 expression differed according to the different glomerular cell types and were not parallel in glomerular cells: alphavbeta3 was decreased (and alphavbeta5 unchanged) on proliferating mesangial cells and alphavbeta5 was increased (and alphavbeta3 unchanged) in podocytes. This may reflect the existence of two distinct regulatory pathways.
Asunto(s)
Antígenos CD/análisis , Proteínas Portadoras/análisis , Mesangio Glomerular/química , Glomerulonefritis Membranoproliferativa/metabolismo , Receptores de Vitronectina/análisis , Anticuerpos Monoclonales , Antígenos CD/biosíntesis , Antígenos CD/inmunología , Biopsia , Antígeno CD47 , Proteínas Portadoras/biosíntesis , Proteínas Portadoras/inmunología , División Celular , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/patología , Mesangio Glomerular/metabolismo , Mesangio Glomerular/patología , Glomerulonefritis Membranoproliferativa/patología , Humanos , Inmunohistoquímica , Integrinas/análisis , Integrinas/biosíntesis , Integrinas/inmunología , Túbulos Renales/química , Túbulos Renales/metabolismo , Túbulos Renales/patología , Receptores de Vitronectina/biosíntesis , Receptores de Vitronectina/inmunologíaRESUMEN
AIMS: We aimed to evaluate the effects of several peptides (substance P, VIP, neuropeptide Y, bombesin, glucagon and somatostatin) on the proliferation, migration and differentiation of human endothelial cells and their modulation by an anti-angiogenic factor, endostatin. METHODS: Human endothelial cells (HUVEC) were isolated from umbilical veins. Their proliferation was measured by the incorporation of tritiated thymidine. Their migration was evaluated by using an haptotactic assay performed in Boyden chambers, after metabolic labeling of HUVEC through (35) S-methionin. Differentiation was evaluated as the capacity for HUVEC to form capillaries. RESULTS: Endothelial cell proliferation was increased by neuropeptide Y, bombesin and glucagon. Somatostatin induced a significant decrease in basal and stimulated endothelial cell proliferation. The migration of HUVEC increased in the presence of substance P, VIP, neuropeptide Y, bombesin, glucagon and somatostatin. The number of capillaries was increased by substance P and VIP and decreased by neuropeptide Y, bombesin and somatostatin. Endostatin induced a significant decrease in endothelial cell proliferation in the basal state and after stimulation by neuropeptide Y and bombesin. Endostatin had no additive effect on the anti-proliferative action of somatostatin. CONCLUSIONS: Our results suggest a role for endocrine peptides in the regulation of tumor angiogenesis. The potent anti-angiogenic effect of somatostatin may promote new therapeutic strategies.
Asunto(s)
Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Neuropéptidos/farmacología , Bombesina/farmacología , Células Cultivadas , Colágeno/farmacología , Endostatinas , Glucagón/farmacología , Humanos , Neuropéptido Y/farmacología , Fragmentos de Péptidos/farmacología , Somatostatina/farmacología , Sustancia P/farmacología , Venas Umbilicales , Péptido Intestinal Vasoactivo/farmacologíaRESUMEN
Liver carcinogenesis is associated with striking changes in the integrin repertoire of hepatocytes, including the overexpression of the laminin and collagen receptors alpha1beta1 and the de novo induction of the laminin receptor alpha6beta1. Our aim was to analyze the role of pro-inflammatory cytokines, interferons and fibrogenic cytokines TGF-beta and FGF2 in the regulation of the expression of beta1 integrins by neoplastic hepatocytes. The 2 human hepatocellular cell lines HepG2 and Hep3B were used as models. Integrin expression was assessed by qualitative methods (immunocytochemistry, Western blotting) and semi-quantitative techniques (FACS, cellular ELISA), before and after stimulation by TNFalpha, IL1-beta, TGF-beta, FGF2, interferon gamma and interferon alpha-2b. HepG2 and Hep3B constitutively expressed alpha1, alpha2, alpha6 and beta1 chains. A 24 to 48-hr stimulation with pro-inflammatory cytokines, TGF-beta and FGF2 induced a significant increase in the concentrations of all integrin chains. The maximum induction was registered for beta1 chain, which presented increases amounting up to 3, 4 and 7 times the control values in the presence of, respectively, TNF alpha/IL1-beta, TGF-beta and FGF2. Interferons had no direct effect on integrin expression and partially antagonized the effects of TNF alpha and TGF-beta. The increased concentrations of integrin chains were associated with an increased membrane expression of the corresponding dimers and with an increased adhesion of stimulated hepatocytes to laminin, which was antagonized by neutralizing anti-beta1 and anti-alpha6 antibodies. Finally, anti-alpha6 antibody inhibited the migration of HepG2 and Hep3B cells in reconstituted basement membrane. Our results suggest that the stimulation of alpha6beta1 integrin expression in hepatocarcinoma cells is essential for cell adhesion and migration.
Asunto(s)
Carcinoma Hepatocelular/metabolismo , Movimiento Celular/fisiología , Integrinas/biosíntesis , Integrinas/fisiología , Neoplasias Hepáticas/metabolismo , Carcinoma Hepatocelular/patología , Adhesión Celular/efectos de los fármacos , Adhesión Celular/fisiología , Membrana Celular/metabolismo , Movimiento Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Factor 2 de Crecimiento de Fibroblastos/farmacología , Citometría de Flujo , Humanos , Immunoblotting , Inmunohistoquímica , Integrina alfa6beta1 , Interferón alfa-2 , Interferón-alfa/farmacología , Interferón gamma/farmacología , Interleucina-1/farmacología , Neoplasias Hepáticas/patología , Proteínas Recombinantes , Factor de Crecimiento Transformador beta/farmacología , Células Tumorales Cultivadas , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Integrins play a pivotal role in organogenesis, by mediating the interactions between differentiating cells and the extracellular matrix. We analyzed the expression of integrins and their ligands during human liver organogenesis. The expression of beta1, beta3, and beta4 integrins and the distribution of several extracellular matrix proteins were studied by immunoperoxidase in fetal liver samples from 5 to 40 weeks' gestation. Hepatoblasts expressed only the beta1, alpha1, alpha5, alpha6, and alpha9 integrin chains. Fetal hepatocytes, emerging at the 8th week of gestation, initially retained the same combination of integrins, but presented a progressive decrease in their expression levels. After 15 weeks' gestation, the expression levels of beta1, alpha1, alpha5, and alpha9 reached levels comparable to those observed in the adult state. Alpha6 expression became undetectable after 30 weeks' gestation. As compared to hepatoblasts, intrahepatic biliary epithelial cells, differentiating at the 8th week of gestation in the ductal plate, were characterized by the progressive loss of alpha1, the marked induction of alpha6, and the de novo acquisition of the beta4, alpha2, and alpha3 integrin chains. The disappearance of integrin receptors for laminin on hepatocytes was associated with the rarefaction of laminin in the perisinusoidal matrix, whereas their induction on biliary epithelial cells was associated with laminin deposition at the point of contact with the ductal plate. In conclusion, integrins likely play an important role in the differentiation of the epithelial and endothelial cell populations of the liver.